This is unusual for peptides
A 2026 observational study suggested that patients without diabetes who took a GLP-1 drug were nearly 2.7 times more likely to be diagnosed with gastroparesis than those in the dataset who did not take a GLP-1 drug
46 Auto-picking yielded 1,498,893 particle projections were subjected to reference-free 2D classification to discard false positive particles or particles categorized in poorly defined classes, producing 485,548 particle projections for further processing
Discontinuation could stem from efficacy, cost, tolerance, and access
The Lean Mass Paradox: Why GLP-1 Data Raised Red Flags In many randomized controlled trials on GLP-1 weight loss drugs, it appears that a disproportionate amount of weight loss comes from lean mass, on the order of 40% of weight loss as lean body mass